A novel hybrid tobacco product that delivers a tobacco flavour note with vapour aerosol (Part 2): In vitro biological assessment and comparison with different tobacco-heating products

Food and Chemical Toxicology

Volumn 106, Issue , 2017, Pages 533-546

  Breheny, Damien ^a   Adamson, Jason ^a   Azzopardi, David ^a   Baxter, Andrew ^a   Bishop, Emma ^a   Carr, Tony ^a   Crooks, Ian ^a   Hewitt, Katherine ^a   Jaunky, Tomasz ^a   Larard, Sophie ^a   Lowe, Frazer ^a   Oke, Oluwatobiloba ^a   Taylor, Mark ^a   Santopietro, Simone ^a   Thorne, David ^a   Zainuddin, Benjamin ^a   Gaça, Marianna ^a   Liu, Chuan ^a   Murphy, James ^a   Proctor, Christopher ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

Author keywords

Hybrid tobacco product; In vitro; Tobacco heating products; Toxicology

Indexed keywords

2 BUTANONE; ACETALDEHYDE; ACETONE; ACROLEIN; BUTYRALDEHYDE; CARBONYL DERIVATIVE; CIGARETTE SMOKE; CROTONALDEHYDE; FORMALDEHYDE; NICOTINE; PROPIONALDEHYDE; AEROSOL; FLAVORING AGENT; PARTICULATE MATTER;

3R4F REFERENCE CIGARETTE; AEROSOL; APOPTOSIS; ARTICLE; CELL VIABILITY; COMMERCIALLY AVAILABLE TOBACCO HEATING PRODUCT; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CYTOTOXICITY; DOSIMETRY; ELECTRONIC CIGARETTE; ENDOTHELIAL DYSFUNCTION; GENOTOXICITY; HYBRID TOBACCO PRODUCT; IN VITRO STUDY; MUTAGENICITY; OXIDATIVE STRESS; PARTICULATE MATTER; PROTOTYPE TOBACCO HEATING PRODUCT; SMOKING; TUMOR PROMOTION; WOUND HEALING; ADULT; CHEMISTRY; DEVICES; FEMALE; HEAT; HUMAN; MALE; MUTAGENESIS; PROCEDURES; PRODUCT SAFETY; STANDARDS; TOBACCO;

ADULT; AEROSOLS; CONSUMER PRODUCT SAFETY; ELECTRONIC CIGARETTES; FEMALE; FLAVORING AGENTS; HOT TEMPERATURE; HUMANS; MALE; MUTAGENESIS; PARTICULATE MATTER; SMOKING; TOBACCO;

EID: 85020190223     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2017.05.023     Document Type: Article

References (68)

1. Adamson, J., Azzopardi, D., Errington, G., Dickens, C., McAughey, J., Gaҫa, M.D., Assessment of an in vitro whole cigarette smoke exposure system: the Borgwaldt RM20S 8-syringe smoking machine. Chem. Cent. J., 5, 2011, 50.
2. ® exposure module using quartz crystal microbalances. Chem. Cent. J., 7, 2013, 50.
3. Adamson, J., Thorne, D., Errington, G., Fields, W., Li, X., Payne, R., Krebs, T., Dalrymple, A., Fowler, K., Dillon, D., Xie, F., Meredith, C., An inter-machine comparison of tobacco smoke particle deposition in vitro from six independent smoke exposure systems. Toxicol. In Vitro 28 (2014), 1320–1328.
4. Adamson, J., Thorne, D., Zainuddin, B., Baxter, A., McAughey, J., Gaça, M., Application of dosimetry tools for the assessment of e-cigarette aerosol and cigarette smoke generated on two different in vitro exposure systems. Chem. Cent., 10, 2016, 74.
5. Azzopardi, D., Haswell, L.E., Foss-Smith, G., Hewitt, K., Asquith, N., Corke, S., Phillips, G., Evaluation of an air–liquid interface cell culture model for studies on the inflammatory and cytotoxic responses to tobacco smoke aerosols. Toxicol. In Vitro 29 (2015), 1720–1729.
6. Azzopardi, D., Patel, K., Jaunky, T., Santopietro, S., Camacho, O.M., McAughey, J., Gaҫa, M., Electronic cigarette aerosol induces significantly less cytotoxicity than tobacco smoke. Tox. Mech. Methods 26 (2016), 477–491.
7. Banerjee, A., Haswell, L.E., Baxter, A., Parmar, A., Azzopardi, D., Corke, S., Thorne, D., Adamson, J., Mushonganono, J., Gaca, M.D., Minet, E.F., Differential gene expression using RNA-seq profiling in a reconstituted airway epithelium exposed to conventional cigarette smoke or electronic cigarette aerosols. Appl. In Vitro Toxico, 7(1), 2017, 888.
8. Baxter, A., Thain, S., Banerjee, A., Haswell, L.E., Parmar, A., Phillips, G., Minet, E.F., Targeted omics analyses, and metabolic enzyme activity assays demonstrate maintenance of key mucociliary characteristics in long term cultures of reconstituted human airway epithelia. Toxicol. In Vitro 29 (2015), 864–875.
9. Berman, M.L., Connolly, G., Cummings, M.K., Djordjevic, M.V., Hatsukami, D.K., Henningfield, J.E., Myers, M., O'Connor, R.J., Parascandola, M., Rees, V., Rice, J.M., Shields, P.G., Providing a science base for the evaluation of tobacco products. Tob. Regul. Sci. 1:1 (2015), 76–93.
10. Breheny, D., Oke, O., Camacho, O.M., Pant, K., Bruce, S.W., LaForce, M.K., Celestin, N., Application of the Bhas 42 Cell Transformation Assay to the Assessment of Novel Tobacco Products. 2015 http://www.bat-science.com/groupms/sites/BAT_9GVJXS.nsf/vwPagesWebLive/DOA29DVY/$FILE/EuroTox_DB_2015_(2).pdf?openelement (Accessed 23 August 2016).
11. Cervellati, F., Muresan, X., Sticozzi, C., Gambari, R., Montagner, G., Forman, H., Torricelli, C., Maioli, E., Valacchi, G., Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. Toxicol. In Vitro 28 (2014), 999–1005.
12. Eriksen, M., Mackay, J., Schluger, N., The Tobacco Atlas Fifth Edition. 2015, American Cancer Society http://www.tobaccoatlas.org/ (Accessed 26 August 2016).
13. European Union, Directive 2014/40/EU of the european parliament and of the council of 3 april 2014. Off. J. Eur. Union L 127 (2014), 1–38.
14. European Commission, Special Eurobarometer 429: Attitudes of Europeans towards Tobacco and Electronic Cigarettes. 2015 http://ec.europa.eu/public_opinion/archives/ebs/ebs_429_en.pdf (Accessed 23 June 2016).
15. Farsalinos, K.E., Le Houezec, J., Regulation in the face of uncertainty: the evidence on electronic nicotine delivery systems (e-cigarettes). Risk Manag. Healthc. Policy 8 (2015), 157–167.
16. Farsalinos, K., Romagna, G., Allifranchini, E., Ripamonti, E., Bocchietto, E., Todeschi, S., Tsiapras, D., Kyrzopoulos, S., Voudris, V., Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int. J. Environ. Res. Public Health 10 (2013), 5126–5146.
17. Food and Drug Administration, Guidance for industry modified risk tobacco product applications. Draft Guid., 2012 http://www.fda.gov/downloads/TobaccoProducts/GuidanceComplianceRegulatoryInformation/UCM297751.pdf (Accessed 23 August 2016).
18. Forster, M., Liu, C., Duke, M.G., McAdam, K.G., Proctor, C.J., An experimental method to study emissions from heated tobacco between 100-200°C. Chem. Cent. J., 9, 2015, 20.
19. Fowles, J., Dybing, E., Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob. Control 12:4 (2003), 424–430.
20. Garcia-Canton, C., Errington, G., Anadon, A., Meredith, C., Characterisation of an aerosol exposure system to evaluate the genotoxicity of whole mainstream cigarette smoke using the in vitro γ-H2AX assay by high content screening. BMC Pharmacol. Toxicol., 15, 2014, 41.
21. Garcia-Perez, I., Lindon, J.C., Minet, E.F., Application of CE–MS to a metabonomics study of human urine from cigarette smokers and non-smokers. Bioanalysis 6 (2014), 2733–2749.
22. Gonzalez-Suarez, I., Martin, F., Marescotti, D., Guedj, E., Acali, S., Johne, S., Dulize, R., Baumer, K., Peric, D., Goedertier, D., Frentzel, S., Ivanov, N.V., Mathis, C., Hoeng, J., Peitsch, M.C., In vitro systems toxicology assessment of a candidate modified risk tobacco product shows reduced toxicity compared to that of a conventional cigarette. Chem. Res. Toxicol. 29:1 (2016), 3–18.
23. Han, S.G., Pant, K., Bruce, S.W., Gairola, C.G., Bhas 42 cell transformation activity of cigarette smoke condensate is modulated by selenium and arsenic. Environ. Mol. Mutagen 57 (2016), 220–228.
24. Haswell, L.E., Thorne, D., Richter, A., Hewitt, K., Cigarette smoke total particulate matter increases mucous secreting cell numbers in vitro: a potential model of goblet cell hyperplasia. Toxicol. In Vitro 24 (2010), 981–987.
25. Health Canada, Determination of “tar”, nicotine and carbon monoxide in mainstream tobacco smoke. Health Can. Method T-115, 1999 http://edge.rit.edu/edge/P10056/public/Health%20Canada%20Nicotine (Accessed 23 August 2016).
26. Ishikawa, S., Kanemaru, Y., Nara, H., Erami, K., Nagata, Y., Assessing the Mutagenic Activities of Smoke from Different Cigarettes in Direct Exposure Experiments Using the Modified Ames Salmonella Assay, 803–804, 2016, 13–21.
27. International Organization for Standardization, Tobacco and Tobacco Products—atmosphere for Conditioning and Testing. ISO 3402:1999, 1999 http://www.iso.org/iso/catalogue_detail.htm?csnumber=28324 (Accessed 23 August 2016).
28. International Organization for Standardization, Cigarettes—determination of Total and Nicotine-free Dry Particulate Matter Using a Routine Analytical Smoking Machine. ISO 4387:2000, 2000 http://www.iso.org/iso/catalogue_detail.htm?csnumber=28323 (Accessed 23 August 2016).
29. International Organization for Standardization, Routine Analytical Cigarette-smoking Machine—definitions and Standard Conditions. ISO 3308:2012, 2012 http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_detail.htm?csnumber=60404 (Accessed 23 August 2016).
30. Jin, M., Earla, R., Shah, A., Earla, R.L., Gupte, R., Mitra, A.K., Kumar, A., Kumar, S., A LC-MS/MS method for concurrent determination of nicotine metabolites and role of CYP2A6 in nicotine metabolism in U937Macrophages: implications in oxidative stress in HIV + smokers. J. Neuroimmune Pharmacol. 7:1 (2012), 289–299.
31. Kaluarachchi, M.R., Boulangé, C.L., Garcia-Perez, I., Lindon, J.C., Minet, E.F., Multiplatform serum metabolic phenotyping combined with pathway mapping to identify biochemical differences in smokers. Bioanalysis 8 (2016), 2023–2043.
32. Kentucky Tobacco Research & Development Center, University of Kentucky Reference Cigarette 3R4F Preliminary Analysis. 2015 https://ctrp.uky.edu/resources/pdf/webdocs/3R4F%20Preliminary%20Analysis.pdf (Accessed 23 June 2016).
33. Kilford, J., Thorne, D., Payne, R., Dalrymple, A., Clements, J., Meredith, C., Dillon, D., A method for assessment of the genotoxicity of mainstream cigarette-smoke by use of the bacterial reverse-mutation assay and an aerosol-based exposure system. Mutat. Res. Genet. Toxicol. Environ. Mutagen 769 (2014), 20–28.
34. Li, X., Nie, C., Shang, P., Xie, F., Liu, H., Xie, J., Evaluation method for the cytotoxicity of cigarette smoke by in vitro whole smoke exposure. Exp. Toxicol. Pathol. 66 (2014), 27–33.
35. Lowe, F., Fearon, I.M., Camacho, O.M., Minet, E., Murphy, J., A framework for the assessment of reduced risk tobacco and nicotine products. Recent Adv. Tob. Sci. 41 (2015), 51–82.
36. Margham, J., McAdam, K., Forster, M., Liu, C., Wright, C., Mariner, D., Proctor, C., Chemical composition of an e-cigarette aerosol: a quantitative comparison with cigarette smoke. Chem. Res. Toxicol., 2016, 10.1021/acs.chemrestox.6b00188 Published online September 18, 2016.
37. McNeill, A., Brose, L.S., Calder, R., Hitchman, S.C., Hajek, P., McRobbie, H., E-cigarettes: an Evidence Update a Report Commissioned by Public Health England., 2015 https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/457102/Ecigarettes_an_evidence_update_A_report_commissioned_by_Public_Health_England_FINAL.pdf (Accessed 23 June 2016).
38. McQuillan, K., Carr, T., Taylor, M., Bishop, E., Fearon, I.M., Examination of the use of human sera as an exposure agent for in vitro studies investigating the effects of cigarette smoking on cellular cardiovascular disease models. Toxicol. In Vitro 29 (2015), 856–863.
39. Organisation for Economic and Cooperative Development, Test No. 471: Bacterial Reverse Mutation Test. 1997 http://www.oecd-ilibrary.org/docserver/download/9747101e.pdf?expires=1471288798&id=id&accname=guest&checksum=9FAE38391CF2402837312CAD703B9197 (Accessed 23 August 2016).
40. Organisation for Economic and Cooperative Development, Guideline 476, In vitro Mammalian Cell Gene Mutation Test. 1997 updated and adopted July 21.
41. Organisation for Economic and Cooperative Development, Guidance Document on the In Vitro Bhas 42 Cell Transformation Assay. Series on Testing and Assessment. No. 231. Paris, 2016 https://www.oecd.org/env/ehs/testing/ENV_JM_MONO(2016)1.pdf (Accessed 03 December 2016).
42. Organisation for Economic and Cooperative Development, Guidance Document on Using Cytotoxicity Tests to Estimate Starting Doses for Acute Oral Systemic Toxicity Tests. Series on Testing and Assessment. No. 129. Paris, 2010 http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/cote=env/jm/mono(2010)20&doclanguage=en (Accessed 29 May 2016).
43. Organisation for Economic and Cooperative Development, Guideline for Testing of Chemicals: In vitro Mammalian Cell Micronucleus Test. 2014 TG 487. Adopted Sept 2014.
44. Onoue, S., Yamamoto, N., Seto, Y., Yamada, S., Pharmacokinetic study of nicotine and its metabolite cotinine to clarify possible association between smoking and voiding dysfunction in rats using UPLC/ESI-MS. Drug. Metab. Pharmacokinet. 26:4 (2011), 416–422.
45. Phillips, J., Kluss, B., Richter, A., Massey, E., Exposure of bronchial epithelial cells to whole cigarette smoke: assessment of cellular responses. Altern. Lab. Anim. 33 (2005), 239–248.
46. Poynton, S., Sutton, J., Goodall, S., Margham, J., Forster, M., Scott, J., Liu, C., McAdam, K., Murphy, J., Proctor, C., A novel hybrid tobacco product that delivers a tobacco flavour note with vapour aerosol (Part 1): product operation and preliminary aerosol chemistry assessment. Food Chem. Toxicol., 2017 Available online 30 May 2017.
47. R.J. Reynolds Tobacco Company, Chemical and Biological Studies: New Cigarette Prototype that Heat Instead of Burn Tobacco. 1988, R.J. Reynolds Tobacco Co., Winston-Salem, NC.
48. Rodgman, A., Perfetti, T.A., The Chemical Components of Tobacco and Tobacco Smoke. second ed., 2013, CRC Press, Boca Raton.
49. Roemer, E., Schramke, H., Weiler, H., Buettner, A., Kausche, S., Weber, S., Berges, A., Stueber, M., Muench, M., Trelles-Sticken, E., Pype, J., Kohlgrueber, K., Voelkel, H., Wittke, S., Mainstream smoke chemistry and in vitro and in vivo toxicity of the reference cigarettes 3R4F and 2R4F. Beitr. Tab. Int. 25 (2012), 316–335.
50. Rogakou, E.P., Pilch, D.R., Orr, A.H., Ivanova, V.S., Bonner, W.M., DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273 (1998), 5858–5868.
51. Salomon, C., Ryan, J., Sobrevia, L., Kobayashi, M., Ashman, K., Mitchell, M., Rice, G.E., Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS One, 8, 2013, e6845.
52. Scheffler, S., Dieken, H., Krischenowski, O., Förster, C., Branscheid, D., Aufderheide, M., Evaluation of e-cigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells. Int. J. Environ. Res. Public Health 12 (2015), 3915–3925.
53. Schoenborn, C.A., Grindi, R.M., Electronic Cigarette Use Amongst Adults. NCHS Data Brief No. 217, October 2015, 2015 http://www.cdc.gov/nchs/data/databriefs/db217.pdf (Accessed 23 June 2016).
54. Scott, K., Saul, J., Crooks, I., Camacho, O.M., Dillon, D., Meredith, C., The resolving power of in vitro genotoxicity assays for cigarette smoke particulate matter. Toxicol. In Vitro 27 (2013), 1312–1319.
55. Stratton, K., Shetty, P., Wallace, R., Bondurant, S., Clearing the Smoke: the Science Base for Tobacco Harm Reduction. 2001, National Academy Press, Washington DC.
56. Taylor, M., Carr, T., Oke, O., Jaunky, J., Breheny, D., Lowe, F., Gaça, M., E-cigarette aerosols induce lower oxidative stress in vitro when compared to tobacco smoke. Toxicol. Mech. Methods 26 (2016), 465–476.
57. Teasdale, J.E., Newby, A.C., Timpson, N.J., Munafò, M.R., White, S.J., Cigarette smoke but not electronic cigarette aerosol activates a stress response in human coronary artery endothelial cells in culture. Drug Alcohol Depend. 163 (2016), 256–260.
58. Thorne, D., Adamson, J., A review of in vitro cigarette smoke exposure systems. Exp. Toxicol. Pathol. 65 (2013), 1183–1193.
59. ® VC 10 in vitro smoke exposure system using dose tools and biological analysis. Chem. Cent. J., 7, 2013, 146.
60. Thorne, D., Dalrymple, A., Dillon, D., Duke, M., Meredith, C., A comparative assessment of cigarette smoke aerosols using an in vitro air-liquid interface cytotoxicity test. Inhal. Toxicol. 27 (2015), 629–640.
61. Thorne, D., Crooks, I., Hollings, M., Seymour, A., Meredith, C., Gaҫa, M., The mutagenic assessment of electronic-cigarettes and tobacco smoke using the Ames assay in strains TA98 and TA100. Mutat. Res. 812 (2016), 29–38.
62. Thorne, D., Larard, S., Baxter, A., Meredith, C., Gaҫa, M., The in vitro assessment of e-cigarette aerosol DNA induced damage using the γ-H2AX assay. Toxicol. Lett. 265 (2016), 170–178.
63. US Department of Health and Human Services, How Tobacco Smoke Causes Disease: the Biology and Behavioral Basis for Smoking-attributable Disease: a Report of the Surgeon General., 2010, Centers for Disease Control and Prevention, Atlanta, USA.
64. US Department of Health and Human Services, The Health Consequences of Smoking 50 Years of Progress: a Report of the Surgeon General, 2014., 2014, Centers for Disease Control and Prevention (US), Atlanta, USA 2014 http://www.surgeongeneral.gov/library/reports/50-years-of-progress/index.html (Accessed 26 August 2016).
65. Volpi, G., Facchinetti, F., Moretto, N., Civelli, M., Patacchini, R., Cigarette smoke and α,β-unsaturated aldehydes elicit VEGF release through the p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts. Br. J. Pharmacol. 163:3 (2011), 649–661.
66. Weisensee, D., Poth, A., Roemer, E., Conroy, L.L., Schlage, W.K., Cigarette smoke-induced morphological transformation of Bhas 42 cells in vitro. Altern. Lab. Anim. 41 (2013), 181–189.
67. West, R., Beard, E., Brown, J., Trends in electronic cigarette use in England. Smok. Toolkit Study STS140122, 2015 http://www.smokinginengland.info/latest-statistics/ (Accessed 23 June 2016).
68. WHO Framework Convention on Tobacco Control, Electronic Nicotine Delivery Systems 2014. July 21, 2014, WHO, Geneva http://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_10-en.pdf (Accessed 23 June 2016).